F.D.A. Approved an Antibody to Protect Infants from R.S.V.
The U.S. Food and Drug Administration has approved an antibody, nirsevimab, which would protect newborns from R.S.V., respiratory syncytial virus. R.S.V. attacks the lung and is the #1 cause of…